Clearstead Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Buy |
330
+16
| +5% | +$5.02K | ﹤0.01% | 1049 |
|
|
2025
Q1 | $95.6K | Buy |
314
+79
| +34% | +$24K | ﹤0.01% | 1007 |
|
|
2024
Q4 | $77.9K | Sell |
235
-85
| -27% | -$28.2K | ﹤0.01% | 1069 |
|
|
2024
Q3 | $107K | Sell |
320
-1
| -0.3% | -$333 | ﹤0.01% | 1013 |
|
|
2024
Q2 | $132K | Buy |
321
+87
| +37% | +$35.8K | ﹤0.01% | 937 |
|
|
2024
Q1 | $90.9K | Buy |
234
+10
| +4% | +$3.89K | ﹤0.01% | 623 |
|
|
2023
Q4 | $68.7K | Sell |
224
-190
| -46% | -$58.2K | ﹤0.01% | 665 |
|
|
2023
Q3 | $100K | Buy |
414
+226
| +120% | +$54.7K | ﹤0.01% | 724 |
|
|
2023
Q2 | $45.2K | Hold |
188
| – | – | ﹤0.01% | 745 |
|
|
2023
Q1 | $35.4K | Buy |
188
+2
| +1% | +$376 | ﹤0.01% | 737 |
|
|
2022
Q4 | $39.5K | Buy |
186
+16
| +9% | +$3.4K | ﹤0.01% | 663 |
|
|
2022
Q3 | $27K | Hold |
170
| – | – | ﹤0.01% | 714 |
|
|
2022
Q2 | $25K | Sell |
170
-21
| -11% | -$3.09K | ﹤0.01% | 748 |
|
|
2022
Q1 | $31K | Buy |
191
+21
| +12% | +$3.41K | ﹤0.01% | 771 |
|
|
2021
Q4 | $37K | Sell |
170
-169
| -50% | -$36.8K | ﹤0.01% | 705 |
|
|
2021
Q3 | $64K | Buy |
339
+189
| +126% | +$35.7K | ﹤0.01% | 569 |
|
|
2021
Q2 | $26K | Hold |
150
| – | – | ﹤0.01% | 661 |
|
|
2021
Q1 | $25K | Hold |
150
| – | – | ﹤0.01% | 633 |
|
|
2020
Q4 | $21K | Hold |
150
| – | – | ﹤0.01% | 622 |
|
|
2020
Q3 | $17K | Hold |
150
| – | – | ﹤0.01% | 604 |
|
|
2020
Q2 | $14K | Hold |
150
| – | – | ﹤0.01% | 566 |
|
|
2020
Q1 | $11K | Buy |
+150
| New | +$11K | ﹤0.01% | 568 |
|